Literature DB >> 17413951

In situ versus whole-globe harvesting of corneal tissue from remote donor sites: effects on initial tissue quality.

Dan B Rootman1, Ellen Wankiewicz, Linda Sharpen, Stephanie A Baxter.   

Abstract

PURPOSE: There are 2 methods of corneal tissue procurement currently in widespread use: in situ extraction of the corneal button directly to preservation media and whole-globe enucleation of eyes with removal of the button to preservation media at a later time. This study evaluates the effects of these 2 procurement procedures on the initial quality of donor corneal tissue.
METHODS: Slit-lamp examination results and endothelial cell counts were compared for a total of 468 donor corneas harvested at 2 remote locations: one where in situ procurement was practiced and the other that used whole-globe enucleation procedures.
RESULTS: In both univariate and multivariate analysis, in situ corneas were found to have a lower incidence of moderate or severe haze and folds in Descemet membrane. No differences in mean endothelial cell counts were noted between the 2 populations of donated tissue.
CONCLUSIONS: In situ procurement of corneal tissue results in higher initial corneal tissue quality than whole-globe procedures.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17413951     DOI: 10.1097/ICO.0b013e31802c9e05

Source DB:  PubMed          Journal:  Cornea        ISSN: 0277-3740            Impact factor:   2.651


  2 in total

1.  Evaluation of active and passive transport processes in corneas extracted from preserved rabbit eyes.

Authors:  Soumyajit Majumdar; Tushar Hingorani; Ramesh Srirangam
Journal:  J Pharm Sci       Date:  2010-04       Impact factor: 3.534

2.  Donor risk factors for graft failure in the cornea donor study.

Authors:  Joel Sugar; Monty Montoya; Mariya Dontchev; Jean Paul Tanner; Roy Beck; Robin Gal; Shawn Gallagher; Ronald Gaster; Ellen Heck; Edward J Holland; Craig Kollman; Jackie Malling; Mark J Mannis; Jason Woody
Journal:  Cornea       Date:  2009-10       Impact factor: 2.651

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.